AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist
  • 2.290
  • +0.210+10.10%
20min DelayMarket Closed Apr 24 16:00 AET
735.90MMarket Cap-14.77P/E (Static)

About Clarity Pharmaceuticals Ltd Company

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology. It operates as a single segment, which is Development of Radiopharmaceuticals. Geographically, it operates in Australia and the United States.

Company Profile

SymbolCU6
Company NameClarity Pharmaceuticals Ltd
Founded2010
MarketASX
Fiscal Year Ends06-30
Address4 Cornwallis Street National Innovation Centre
CitySydney
CountryAustralia
Zip Code2015
Phone+61 292094037
Share RegistryMUFG CORPORATE MARKETS (AU) LIMITED LIBERTY PLACE, LEVEL 41, 161 CASTLEREAGH ST, SYDNEY, NSW, AUSTRALIA, 2000 1300 554 474

Company Executives

  • Name
  • Position
  • Salary
  • Michelle Parker
  • Director and Chief Executive Officer
  • --
  • Dr. Colin Biggin, PhD
  • Director and Chief Operating Officer
  • --
  • Rosanne Robinson
  • Lead Independent Director
  • --
  • Dr. Thomas Ramdahl
  • Independent Director
  • --
  • Dr. Christopher G. Roberts,PhD
  • Independent Director
  • --
  • Dr. Alan Taylor, PhD
  • Executive Chairperson of the Board
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More